DNA奈米技術市場－全球產業規模、佔有率、趨勢、競爭格局、機會及預測：按類型、應用、最終用戶、地區及競爭格局分類，2021-2031年

全球DNA奈米技術市場預計將從2025年的59.1億美元成長到2031年的190.7億美元，複合年成長率為21.56%。

在該領域，合成核酸結構經過精確設計，可用於建構功能性奈米裝置，其應用範圍涵蓋標靶藥物遞送、分子計算和高密度資料儲存等領域。市場擴張的主要驅動力是：對能夠最大限度減少脫靶效應的高精度治療藥物的需求日益成長，以及對可擴展、高密度資料儲存解決方案的需求不斷增加。這些根本性的實用因素為醫療和資訊科技領域的長期商業性應用奠定了堅實的基礎，確保了該技術能夠超越短暫的行業趨勢，實現持續成長。

市場促進因素

隨著臨床醫生擴大利用DNA奈米結構以前所未有的特異性遞送治療藥物，對標靶藥物遞送系統日益成長的需求正顯著推動市場擴張。合成DNA籠和DNA摺紙結構可以被編程，僅在檢測到特定分子觸發訊號時才釋放藥物，從而最大限度地降低全身毒性，並提高對癌症等複雜疾病的療效。這種向精準醫療的轉變得到了聯邦政府的大力支持，美國國立衛生研究院（NIH）每年在奈米技術驅動的診斷和治療技術方面投入超過9億美元，正如「總統2025會計年度預算國家奈米技術舉措補充文件」中所強調的那樣。此外，DNA摺紙和合成技術的創新正在加速這一發展勢頭，克服了製造規模化和誤差率等傳統瓶頸。高通量寡核苷酸合成技術的進步使得經濟高效地生產無缺陷DNA鏈成為可能，這對於醫療設備和高密度資料儲存至關重要。該行業的成熟度也體現在基礎設施提供者的財務表現上。例如，Twist Bioscience在其2025年第三季財報中報告稱，其合成生物學銷售額達到3520萬美元，反映出其基於矽的DNA合成平台的應用日益廣泛。此外，總統2025年的預算提案中包含22億美元的國家奈米技術計畫撥款申請，進一步鞏固了聯邦政府對基礎研究和開發的持續支持。

市場挑戰

高成本和技術複雜性是DNA奈米技術在全球發展和市場擴張的主要障礙。雖然在實驗室環境下可以製備出完美無瑕、精確的DNA奈米結構，但將其應用於工業規模的大規模生產時，往往會產生缺陷，從而影響奈米裝置的功能。這種生產瓶頸迫使企業維持高價以收回巨額資本投資，導致該技術的應用僅限於利潤豐厚的利基領域，例如特殊療法，而不是廣泛的工業或消費領域。無法實現經濟高效的大規模生產，造成了高度集中的商業環境，只有極少數創新具有經濟可行性。根據再生醫學聯盟預測，到2025年，全球整體約75%的依賴核酸工程技術的先進治療領域的收入將來自不到10種市售產品。這種驚人的市場集中度凸顯了生產限制如何有效地阻礙了廣泛的研發管線，使大多數DNA奈米技術創新無法獲得廣泛的市場滲透。

市場趨勢

將人工智慧 (AI) 整合到奈米結構最佳化中，從根本上改變了 DNA 奈米技術的設計階段，降低了複雜幾何形狀建模的計算負擔。生成式演算法使研究人員能夠高精度地預測折疊式路徑和結構穩定性，以數據驅動的精確性取代了迭代試驗誤法。這項技術飛躍正在迅速席捲整個產業。正如英偉達在 2024 年 11 月的報告所述，全球眾多製藥和生物技術公司正在採用開放原始碼框架來加速藥物開發和最佳化分子設計，這表明在功能性奈米裝置的開發中，運算能力正變得與實驗室合成同等重要。同時，產學研策略夥伴關係對於技術商業化至關重要，它能夠彌合基礎核酸研究與可擴展市場應用之間的差距。透過利用成熟的合成生物學晶圓代工廠的生產能力，學術機構和早期創新者可以避免內部生產帶來的高昂資本投入，從而加速從原型到產品的轉換。這種合作模式正在迅速擴展。例如，Ginkgo Bioworks在2024年第三季財報中宣布，其平台新增了25個項目。這反映出外部研發機構正利用集中式基礎設施來推進DNA技術的發展。此類生態系統對於克服生產瓶頸和拓展具有商業性可行性的DNA奈米結構產品線至關重要。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球DNA奈米技術市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（結構性DNA奈米技術、動態DNA奈米技術）
  • 依應用領域（標靶藥物傳遞、智慧藥丸、奈米光刻等）
  • 按最終用戶（生物技術和製藥公司、學術和研究機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美DNA奈米技術市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲DNA奈米技術市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區DNA奈米技術市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲DNA奈米技術市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲DNA奈米技術市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球DNA奈米技術市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Gattaquant
• Nanobio Designs
• Tilibit
• Helixworks
• SomaLogic
• EnaChip
• Ginkgo Bioworks
• Nanolab Technologies
• Nanogami
• DNA Nanobots, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global DNA Nanotechnology Market is projected to grow substantially from USD 5.91 Billion in 2025 to USD 19.07 Billion by 2031, at a robust CAGR of 21.56%. This field involves the precise engineering of synthetic nucleic acid structures to create functional nanoscale devices, with applications ranging from targeted drug delivery to molecular computing and high-density data storage. The market's expansion is primarily fueled by the increasing demand for high-precision therapeutics that minimize off-target effects and the rising need for scalable, high-density data storage solutions. These fundamental utility drivers establish a strong foundation for long-term commercial adoption in both medical and information technology sectors, ensuring sustained growth beyond transient industry trends.

Market Driver

Market expansion is significantly propelled by the increasing demand for targeted drug delivery systems, as clinicians increasingly utilize DNA nanostructures to deliver therapeutic payloads with unprecedented specificity. Synthetic DNA cages and origami structures can be programmed to release drugs exclusively upon detecting specific molecular triggers, thereby minimizing systemic toxicity and enhancing efficacy for complex conditions such as cancer. This shift toward precision medicine is supported by substantial federal funding, with the National Institutes of Health investing over $900 million annually in nanotechnology-enabled diagnostic and therapeutic technologies, as highlighted in the 'National Nanotechnology Initiative Supplement to the President's 2025 Budget'. Furthermore, technological innovations in DNA origami and synthesis accelerate this momentum by overcoming historical bottlenecks in manufacturing scalability and error rates. Advances in high-throughput oligonucleotide synthesis now facilitate the cost-effective production of defect-free DNA strands, crucial for both medical devices and high-density data storage. This industrial maturation is evident in the financial performance of infrastructure providers; for instance, Twist Bioscience reported $35.2 million in Synthetic Biology revenue in its Fiscal Third Quarter 2025 Financial Results, reflecting the expanding adoption of its silicon-based DNA synthesis platform. The President's 2025 Budget's request of $2.2 billion for the National Nanotechnology Initiative further ensures continued federal backing for foundational research and development.

Market Challenge

The high cost and technical complexity of scaling production present significant impediments to the growth and broader market expansion of global DNA nanotechnology. While precise defect-free DNA nanostructures can be created in laboratory settings, translating this to industrial volumes frequently introduces defect rates that compromise the functionality of nanoscale devices. This manufacturing bottleneck compels companies to maintain elevated price points to recover substantial capital expenditures, thereby restricting the technology's adoption to niche, high-margin applications like specialized therapeutics, rather than wider industrial or consumer sectors. This inability to achieve cost-effective, high-volume manufacturing leads to a highly concentrated commercial landscape where only a fraction of innovations attain financial viability. According to the Alliance for Regenerative Medicine, in 2025, approximately 75% of global revenue in the advanced therapy sector, which heavily relies on these nucleic acid engineering capabilities, was generated by fewer than ten commercialized products. This stark market concentration underscores how production constraints effectively stifle the broader pipeline, preventing most DNA nanotechnology innovations from achieving widespread market penetration.

Market Trends

The integration of Artificial Intelligence (AI) for nanostructure optimization is fundamentally reshaping the design phase of DNA nanotechnology by reducing the computational burden of modeling complex geometries. Generative algorithms now enable researchers to predict folding pathways and structural stability with high fidelity, replacing iterative trial-and-error methods with data-driven precision. This technological leap is rapidly gaining industrial traction; as reported by NVIDIA in November 2024, numerous global pharmaceutical and techbio organizations have adopted open-source frameworks to accelerate therapeutic development and optimize molecular designs, indicating that computational proficiency is becoming as critical as wet-lab synthesis in developing functional nanodevices. Concurrently, strategic industry-academia partnerships for technology commercialization are crucial for bridging the gap between fundamental nucleic acid research and scalable market applications. By leveraging the manufacturing capabilities of established synthetic biology foundries, academic and early-stage innovators can bypass the capital-intensive barriers of in-house fabrication, thereby accelerating the transition from prototype to product. This collaborative model is expanding rapidly; Ginkgo Bioworks, for instance, reported adding 25 new programs to its platform in its Third Quarter 2024 Financial Results, reflecting a surge in external R&D entities utilizing centralized infrastructure to advance their DNA-based technologies. Such ecosystems are essential for overcoming production bottlenecks and diversifying the pipeline of commercially viable DNA nanostructures.

Key Market Players

• Gattaquant
• Nanobio Designs
• Tilibit
• Helixworks
• SomaLogic
• EnaChip
• Ginkgo Bioworks
• Nanolab Technologies
• Nanogami
• DNA Nanobots, LLC

Report Scope

In this report, the Global DNA Nanotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

DNA Nanotechnology Market, By Type

• Structural DNA Nanotechnology
• Dynamic DNA Nanotechnology

DNA Nanotechnology Market, By Application

• Targeted Drug Delivery
• Smart Pills
• Nanolithography
• Others

DNA Nanotechnology Market, By End User

• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutions
• Others

DNA Nanotechnology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global DNA Nanotechnology Market.

Available Customizations:

Global DNA Nanotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global DNA Nanotechnology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Structural DNA Nanotechnology, Dynamic DNA Nanotechnology)
  • 5.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
  • 5.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America DNA Nanotechnology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States DNA Nanotechnology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada DNA Nanotechnology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico DNA Nanotechnology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe DNA Nanotechnology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany DNA Nanotechnology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France DNA Nanotechnology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom DNA Nanotechnology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy DNA Nanotechnology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain DNA Nanotechnology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific DNA Nanotechnology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China DNA Nanotechnology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India DNA Nanotechnology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan DNA Nanotechnology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea DNA Nanotechnology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia DNA Nanotechnology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa DNA Nanotechnology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia DNA Nanotechnology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE DNA Nanotechnology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa DNA Nanotechnology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America DNA Nanotechnology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil DNA Nanotechnology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia DNA Nanotechnology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina DNA Nanotechnology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global DNA Nanotechnology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Gattaquant
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Nanobio Designs
• 15.3. Tilibit
• 15.4. Helixworks
• 15.5. SomaLogic
• 15.6. EnaChip
• 15.7. Ginkgo Bioworks
• 15.8. Nanolab Technologies
• 15.9. Nanogami
• 15.10. DNA Nanobots, LLC

16. Strategic Recommendations

17. About Us & Disclaimer